NIHR Oxford Biomedical Research Centre

Enabling translational research through partnership

MENUMENU
  • About
    • About the NIHR Oxford Biomedical Research Centre
    • NIHR Oxford BRC impact
    • Steering Committee
    • Promoting equality, diversity and inclusion in research
    • Current Vacancies
    • Stay in Touch
    • Contact Us
  • Research

        • Research Overview
        • Clinical Research Facility
        • Health Economics
        • Ethics in the NIHR Oxford BRC
        • Medical Statistics
        • Infections in Oxfordshire Database (IORD)
        • 15 Research Themes

        • Cancer
        • Cardiovascular Medicine
        • Digital Health from Hospital to Home
        • Gene and Cell Therapy
        • Genomic Medicine
        • Imaging
        • Inflammation across Tissues
        • Life-saving Vaccines
        • Metabolic Experimental Medicine
        • Modernising Medical Microbiology and Big Infection Diagnostics
        • Musculoskeletal
        • Preventive Neurology
        • Respiratory Medicine
        • Surgical Innovation, Technology and Evaluation
        • Translational Data Science
  • Patient and Public Involvement
    • For patients and the public
    • For researchers
    • More information
  • Training Hub
    • Training Hub Overview
    • Clinical Academic Pathway
    • Internships
    • Pre-doctoral Research Fellowships
    • Senior Research Fellowships
    • Research Training Bursaries
    • Doctoral Awards
    • Post-Doctoral Awards
    • PARC Programme
    • Other funding
    • Leadership Training
    • Useful Links
    • Training and Education Resources
    • Upcoming Training Events & Courses
  • Industry
    • Collaborate with Oxford BRC
    • Who Do We Work With?
    • Events
    • Further Information and Additional Resources
    • Contacts for Industry
  • Videos
  • News
  • Events

** HEALTH RESEARCH SHOWCASE THURSDAY 29 MAY 2025 **

News

You are here: Home > COVID-19 > Oxford researchers release cheap, quick COVID-19 antibody test

Oxford researchers release cheap, quick COVID-19 antibody test

29 March 2021 · Listed under COVID-19, Inflammation across Tissues

An international research team led by Oxford University scientists has developed a portable test for antibodies that fight the novel coronavirus that causes COVID-19.

Model of COVID-19 molecules
Photo: NIH

The test, which spots the presence of virus-fighting antibodies rather than a coronavirus infection, can be adapted to work on blood from a finger prick, making it quick and easy to use. 

The research team, which is supported by the NIHR Oxford Biomedical Research Centre, trialled the test on patients with COVID-19, but now hope to adapt it to identify those who have successfully generated antibodies after a vaccine, versus those who may need a booster.

The paper, ‘A haemagglutination test for rapid detection of antibodies to SARS-CoV-2’, was published in Nature Communications.

The team – which includes scientists from Taiwan, India, Thailand and France, as well as researchers from UK universities and the NHS – hope that the large-scale use of their tests might help researchers and policy-makers track levels of protective immunity in the community.

Antibodies are large proteins that lock onto and help the body’s immune system fight off disease-causing organisms, such as the novel coronavirus that causes COVID-19. Both infection with the virus and vaccines can generate antibodies.

There are already several commercial tests that can detect whether someone has antibodies against this coronavirus, but these tests are expensive and usually need a central laboratory to analyse them. This is especially a problem in low-income countries.

Study lead Professor Alain Townsend from the University of Oxford’s MRC Human Immunology Unit, based at the John Radcliffe Hospital, said: “Our test is very cheap to produce, so we are using existing funding from charitable donations to offer 10 million tests for research purposes to countries that cannot support very high-tech solutions.”

The test relies on linking a part of the viral spike protein to the surface of red blood cells. When antibodies to the virus are present they create a clump of red blood cells. This clump is big enough to be seen by eye.

The test also does not require any special equipment or take a long time to show the results, and is accurate: “It correctly identifies coronavirus spike protein antibodies 90% of the time, with less than a 1% false positive rate.”

Professor Townsend said: “All we need to do is mix a low-cost reagent with a small blood sample, and the clumping of the red cells after one hour shows whether the blood sample contained antibodies against the novel coronavirus or not.”

The Townsend-Jeantet charitable trust, run by Professor Townsend, will fund the production of sufficient reagent for 10 million test wells by an Oxford company, Absolute Antibody.

Professor Townsend said: “We are already distributing our test reagent to researchers who need them anywhere in the world, free of charge. So far, we supplied our tests to researchers in 21 different countries, with major studies using our antibody test in Norway, Colombia, Taiwan and Sri Lanka.”

The team have also developed new versions of the reagent that that can test for antibodies to the new variant viruses through a recent generous donation from a local donor.

The researchers say the test can be adapted to work using blood from a finger prick sample, meaning it can be easily carried out in a variety of locations, even in the home. They now plan to use this very simple test in future trials to see if it can identify those who are protected against COVID-19 from those who may need a booster vaccination.

Professor Alison Simmons, Director of the MRC Human Immunology Unit, said: “This study and the research developments by the team are a very valuable asset to our toolbox in our fight against the novel coronavirus.

“With better ways of testing antibody levels and understanding immune defences of individuals and across populations, we increasingly take steps towards being able to protect more people globally and control the spread of the virus.”  

← New study finds strong immune response following COVID-19 vaccination
Risk of severe COVID-19 from asthma and other respiratory diseases may be only modestly increased, new analysis suggests →

Other news

News Categories

News by Month

See all news

Subscribe to the Oxford BRC Newsletter

Keep informed about the work of the Oxford BRC by subscribing to our Mailchimp e-newsletter. It is produced several times a year and delivers news and information about upcoming events straight to your inbox.

Subscribe Now

Feedback

We’d love to hear your feedback. Please contact us at [email protected]

Oxford BRC on Social Media

  • Bluesky
  • Facebook
  • LinkedIn
  • Threads
  • Twitter
  • YouTube
  • Data Control and Privacy
  • Accessibility
  • Our Partners
  • Disclaimer
  • Contact

Copyright © 2025 NIHR Oxford Biomedical Research Centre